Experimental cancer drug THOR-707 trial halted early

NCT ID NCT04009681

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times

Summary

This study tested an experimental drug called THOR-707, alone or with other treatments, in adults with advanced or metastatic solid tumors. The main goals were to find safe doses and see if the drug could shrink tumors. The trial was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number- 6001

    Santiago, Chile

  • Investigational Site Number-1001

    San Antonio, Texas, 78229, United States

  • Investigational Site Number-1002

    Houston, Texas, 77030, United States

  • Investigational Site Number-1003

    Nashville, Tennessee, 37203, United States

  • Investigational Site Number-1004

    Sarasota, Florida, 34232, United States

  • Investigational Site Number-1005

    Denver, Colorado, 80218, United States

  • Investigational Site Number-1007

    Dallas, Texas, 75032, United States

  • Investigational Site Number-1008

    Scottsdale, Arizona, 85250, United States

  • Investigational Site Number-2001

    Perth, Australia

  • Investigational Site Number-2002

    Victoria, Australia

  • Investigational Site Number-2003

    Victoria, Australia

  • Investigational Site Number-2004

    New South Whales, Australia

  • Investigational Site Number-4002

    Singapore, Singapore

  • Investigational Site Number-5001

    Barcelona, Spain

  • Investigational Site Number-5002

    Madrid, Spain

  • Investigational Site Number-5003

    Madrid, Spain

  • Investigational Site Number-5004

    Madrid, Spain

  • Investigational Site Number-5005

    Madrid, Spain

  • Investigational Site Number-5006

    Barcelona, Spain

  • Investigational Site Number-5007

    Barcelona, Spain

  • Investigational Site Number-5105

    Madrid, Spain

  • Investigational Site Number-6002

    Santiago, Chile

  • Investigational Site Number-7002

    Buenos Aires, Argentina

  • Investigational Site-4001

    Singapore, Singapore

Conditions

Explore the condition pages connected to this study.